Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125970781 | 12597078 | 1 | I | 0 | 20160726 | 20160726 | DIR | 19.00 | YR | M | N | 242.00000 | LBS | 20160725 | N | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125970781 | 12597078 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | N | D | AJSO5215 | 20170430 | 0 | 30 | DF | COATED TABLET | HS |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125970781 | 12597078 | 1 | Affective disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125970781 | 12597078 | LT |
| 125970781 | 12597078 | OT |
| 125970781 | 12597078 | HO |
| 125970781 | 12597078 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125970781 | 12597078 | Eating disorder | |
| 125970781 | 12597078 | Gene mutation | |
| 125970781 | 12597078 | Polycythaemia | |
| 125970781 | 12597078 | Polycythaemia vera | |
| 125970781 | 12597078 | Tardive dyskinesia | |
| 125970781 | 12597078 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125970781 | 12597078 | 1 | 20110715 | 20160515 | 0 |